Tumor necrosis factor-α mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage

Hypertension

Volumn 54, Issue 1, 2009, Pages 150-156

  Vecchione, Carmine ^a   Frati, Alessandro ^b   Di Pardo, Alba ^a   Cifelli, Giuseppe ^a   Carnevale, Daniela ^c   Gentile, Maria Teresa ^a   Carangi, Rosa ^a   Landolfi, Alessandro ^a   Carullo, Pierluigi ^a   Bettarini, Umberto ^a   Antenucci, Giovanna ^a   Mascio, Giada ^a   Busceti, Carla Letizia ^a   Notte, Antonella ^a   Maffei, Angelo ^a   Cantore, Gian Paolo ^b   Lembo, Giuseppe ^c,d  

^a IRCCS NEUROMED   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cerebrovascular disease; Cytokines; Inflammation; Oxidant stress; Subarachnoid hemorrhage

Indexed keywords

RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRIPHENYLTETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; CISTERNA MAGNA; CONTROLLED STUDY; HEMOLYSIS; HISTOPATHOLOGY; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUBARACHNOID HEMORRHAGE; ULTRASOUND; VASOCONSTRICTION;

ANIMALS; ANTIBODIES, MONOCLONAL; BASILAR ARTERY; HEMOLYSIS; MICE; MICE, INBRED C57BL; NADPH OXIDASE; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; RAC GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 67649840915     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.128124     Document Type: Article

References (39)

1. SchievinkWI. Intracranial aneurisms. New Eng J Med. 1997;336:28-40.
2. Longstreth WT Jr, Nelson LM, Loepsell TD, van Belle G. Clinical course of spontaneous subarachnoid hemorrhage; a population-based study in King Country, Washington. Neurology. 1993;43:712-718.
3. Hop JW, Rinkel GJ, Algra A, van Gijn J. Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage. Stroke. 1998;29: 798-804.
4. Charpentier C, Charpentier C, Audibert G, Guillemin F, Civit T, Ducrocq X, Bracard S, Hepner H, Picard L, Laxenaire MC. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke. 1999;30:1402-1408.
5. Vajkoczy P, Horn P, Bauhuf C, Munch E, Hubner U, Ing D, Thome C, Poeckler-Schoeninger C, Roth H, Schmiedek P. Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm. Stroke. 2001;32:498-505.
6. Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2003;2:614-621.
7. Pluta RM, Dejam A, Grimes G, Gladwin MT, Oldfield EH. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA. 2005;293:1477-1484.
8. Sehba FA, Bederson JB. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res. 2006;28:381-398.
9. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2006;26: 1341-1353.
10. Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991;22:971-982.
11. Hasan RN, Schafer AI. Hemin upregulates Egr-1 expression in vascular smooth muscle cells via reactive oxygen species ERK-1/2-Elk-1 and NF-kappaB. Circ Res. 2008;102:42-50.
12. Vecchione C, Aretini A, Marino G, Bettarini U, Poulet R, Maffei A, Sbroggio M, Pastore L, Gentile MT, Notte A, Iorio L, Hirsch E, Tarone G, Lembo G. Selective Rac-1 inhibition protects from diabetes-induced vascular injury. Circ Res. 2006;98:218-225.
13. Vecchione C, Patrucco E, Marino G, Barberis L, Poulet R, Aretini A, Maffei A, Gentile MT, Storto M, Azzolino O, Brancaccio M, Colussi GL, Bettarini U, Altruda F, Silengo L, Tarone G, Wymann MP, Hirsch E, Lembo G. Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ. J Exp Med. 2005;201: 1217-1228.
14. Sadrzadeh SM, Eaton JW. Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. J Clin Invest. 1988;82:1510-1515.
15. McFaul SJ, Bowman PD, Villa VM. Hemoglobin stimulates the release of proinflammatory cytokines from leukocytes in whole blood. J Lab Clin Med. 2000;135:263-269.
16. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53:123-135.
17. Matz PG, Sundaresan S, Sharp FR, Weinstein PR. Induction of HSP70 in rat brain following subarachnoid hemorrhage produced by endovascular perforation. J Neurosurg. 1996;85:138-145.
18. Li J, Li W, Liu W, Altura BT, Altura BM. Mechanisms of hydroxyl radical-induced contraction of rat aorta. Eur J Pharmacol. 2004;499: 171-178.
19. Sehba FA, Schwartz AY, Chereshnev I, Bederson JB. Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2000;20:604-611.
20. Nishihashi T, Trandafir CC, Wang A, Ji X, Shimizu Y, Kurahashi K. Hypersensitivity to hydroxyl radicals in rat basilar artery after subarachnoid hemorrhage. J Pharmacol Sci. 2006;100:234-236.
21. Cosentino F, Sill JC, Katusic ZS. Role of superoxide anions in the mediation of endothelium dependent contractions. Hypertension. 1994;23:229-235.
22. Jernigan NL, Walker BR, Resta TC. Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol. 2008;295:L515-L529.
23. Miller AA, Drummond GR, Schmidt HH, Sobey CG. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res. 2005;97:1055-1062.
24. Didion SP, Faraci FM. Effects of NADH and NADPH on superoxide levels and cerebral vascular tone. Am J Physiol Heart Circ Physiol. 2002;282:H688-H695.
25. Shin HK, Lee JH, Kim KY, Kim CD, Lee WS, Rhim BY, Hong KW. Impairment of autoregolatory vasodilation by NAD(P)H oxidase-dependent superoxide generation during acute stage of subarachnoid hemorrhage in rat pial artery. J Cereb Blood Flow Met. 2002;22: 869-877.
26. McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearistein RD, Warner DS. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke. 2002;33:2317-2323.
27. Zheng JS, Zhan RY, Zheng SS, Zhou YQ, Tong Y, Wan S. Inhibition of NADPH oxidase attenuates vasospasm after experimental subarachnoid hemorrhage in rats. Stroke. 2005;36:1059-1064.
28. Mathiesen T, Edner G, Ulfarsson E, Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg. 1997;87:215-220.
29. Figueiredo RT, Fernandez PL, Mourao-SaDS, Porto BN, DutraFF, Alves LS, Oliveira MF, Oliveira PL, Graca-Souza AV, Bozza MT. Characterization of heme as activator of Toll-like receptor 4. J Biol Chem. 2007;282:20221-20229.
30. Zhou ML, Wu W, Ding YS, Zhang FF, Hang CH, Wang HD, Cheng HL, Yin HX, Shi JX. Expression of Toll-like receptor 4 in the basilar artery after experimental subarachnoid hemorrhage in rabbits: a preliminary study. Brain Res. 2007;1173:110-116.
31. Vila E, Salaices M. Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol. 2005;288:H1016-H1021.
32. Kai Y, Hirano K, Maeda Y, Nishimura J, Sasaki T, Kanaide H. Prevention of the hypercontractile response to thrombin by proteinase-activated receptor-1 antagonist in subarachnoid hemorrhage. Stroke. 2007;38:3256-3265.
33. Xie A, Aihara Y, Bouryi VA, Nikitina E, Jahromi BS, Zhang ZD, Takahashi M, Macdonald RL. Novel mechanism of endothelin-1 induced vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2007;27:1692-1701.
34. Hansen-Scwartz J, Ansar S, Edvinsson L. Cerebral vasoconstriction after subarachnoid hemorrhage-role of changes in vascular receptor phenotype. Front Biosci. 2008;13:2160-2164.
35. Harada T, Mayberg MR. Inhibiton of delayed arterial narrowing by the iron-chelating agent deferoxamine. J Neurosurg. 1992;77:763-767.
36. Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage: a report of the Cooperative Aneurysm Study. J Neurosurg. 1995;82:786-790.
37. Pluta RM, Oldfield EH, Boock RJ. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg. 1997;87:746-751.
38. Scott DL, Kingsley GH. Tumor necrosis factor inhibitors for rheumatoid arthritis. New Eng J Med. 2006;355:704-712.
39. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn's disease. New Eng J Med. 2004;350:876-885.